# Getinge Posts 2.1% Organic Sales Growth as Adjusted EBITA Margin Climbs to 15.1%

> Getinge reported 2.1% organic sales growth and a 15.1% adjusted EBITA margin for Q3 2026, with free cash flow of SEK 1,302 million and a maintained full-year outlook.

- Published: 2026-10-21T06:54:32+00:00
- Section: Earnings & Results
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-21/getinge-q3-2026-profit-margin-rises
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/getinge-interim-report-july-september-2026-increased-profitability-strong-cash-flow-and-higher-customer-satisfaction-302915080.html)

## Key takeaways

- Getinge's adjusted EBITA margin rose to 15.1% in Q3 2026, helped by SEK 45 M in tariff refunds and about SEK 36 M in currency effects.
- Free cash flow reached SEK 1,302 M, up from SEK 793 M a year earlier.
- Getinge maintained its full-year 2026 outlook for organic net sales growth of 3-5%.

[Getinge](https://akta.pro/company-profiles/0000kmy/getinge) reported organic sales growth of 2.1% and organic order intake growth of 2.6% for the third quarter of 2026, with an adjusted EBITA margin of 15.1% and free cash flow of SEK 1,302 million. The Swedish medical technology company published the figures on October 21, 2026, according to [PR Newswire](https://www.prnewswire.com/news-releases/getinge-interim-report-july-september-2026-increased-profitability-strong-cash-flow-and-higher-customer-satisfaction-302915080.html).

## Getinge's Q3 2026 Results in Detail

Adjusted gross profit came to SEK 4,343 M, a margin of 51.4%, and adjusted EBITA was SEK 1,278 M. Adjusted earnings per share were SEK 3.10. The adjusted EBITA margin was helped by tariff refunds of SEK 45 M and year-on-year currency effects of approximately SEK 36 M; excluding those factors, the margin improved by more than 1 percentage point to 14.3%.

"We delivered organic growth both in order intake and in sales during the quarter, at the same time we increased profitability and generated strong cash flow," said Mattias Perjos, President and CEO of Getinge. Sales growth was driven mainly by Acute Care Therapies, while Surgical Workflows contributed stable order intake, largely in operating room equipment. Perjos said the Life Science situation remains mixed, with the high-margin Sterile Transfer category performing strongly while the project-based WIS category, which includes washer-disinfectors, was affected by low investment activity in the pharma segment.

Getinge initiated the launch of Cardiohelp II, its next-generation ECLS therapy platform, in CE countries and Hong Kong in the latter part of the quarter. The company also received 510(k) clearance for a new Edi catheter for premature infants weighing 500-1,000 grams, and launched Torin Plan Optimizer, an AI-powered system for managing surgical resources.

## Getinge's Product Launches and Partnerships

Getinge is a Swedish medical technology company that designs, manufactures and services surgical, ICU and ventilation, sterile-transfer and pharmaceutical cleanroom equipment for hospitals and life-science manufacturers, according to akta.pro [company records](https://akta.pro/company-data). The same records list a March 2026 launch of the Cardiohelp II next-generation ECLS system with a CE mark, and a June 2026 opening of a Digital OR Hub in Hamburg, Germany, to develop an intelligent digital operating room ecosystem.

## Getinge's Earlier FDA Clearance and Short Interest

On October 13, 2026, Getinge received FDA 510(k) clearance for a 6Fr/48 cm Edi catheter for premature infants weighing 500-1,000 grams, with the catheter already available outside the U.S. since 2025 and planned for the U.S. market by the end of 2026, news.cision.com reported. On October 7, 2026, Affarsvarlden reported that AQR Capital Management had reduced its stake in Getinge and was no longer a public short seller, leaving total public short interest at 2.94% of capital.

## Getinge's Conference Call and Full-Year Outlook

Getinge maintained its outlook for organic net sales growth of 3-5% for the full year 2026. A conference call on October 21, 2026, at 10.00-11.00 a.m. CEST was hosted by Perjos and CFO Agneta Palmér.

## Companies in this story

- [Getinge company profile](https://akta.pro/company-profiles/0000kmy/getinge) · website: https://www.getinge.com

---
News for Agent · https://newsforagent.com/llms.txt